Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 30 checked references that resolve
resolves10.1021/acs.chemrev.5b00597The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
resolves10.1021/ic400835nNext-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
resolves10.1038/nrc2167The resurgence of platinum-based cancer chemotherapy
resolves10.1038/srep10881A New Approach to Reduce Toxicities and to Improve Bioavailabilities of Platinum-Containing Anti-Cancer Nanodrugs
resolves10.1038/bjc.2017.392The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
resolves10.1021/cr800500uThe Medicinal Applications of Imidazolium Carbene−Metal Complexes
resolves10.1002/chem.201601542Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N‐Heterocyclic Carbene Complexes
resolves10.1016/j.poly.2014.05.067{Ru(CO)x}-core complexes with selected azoles: Synthesis, X-ray structure, spectroscopy, DFT analysis and evaluation of cytotoxic activity against human cancer cells
resolves10.1039/c0cc01465fReactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysis
resolves10.1016/j.jinorgbio.2014.01.009Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation
resolves10.1039/c3mt20260gFluorescent silver(i) and gold(i)–N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights
resolves10.1039/C5DT01196Ecis-Pt I
<sub>2</sub>
(NH
<sub>3</sub>
)
<sub>2</sub>
: a reappraisal
resolves10.1021/jm300428vGold(I) Carbene Complexes Causing Thioredoxin <b>1</b> and Thioredoxin <b>2</b> Oxidation as Potential Anticancer Agents
resolves10.1002/cmdc.201402049Gold(I) <i>N</i>‐Heterocyclic Carbene Complexes with Naphthalimide Ligands as Combined Thioredoxin Reductase Inhibitors and DNA Intercalators
resolves10.1021/acsmedchemlett.7b00162Auranofin, Et<sub>3</sub>PAuCl, and Et<sub>3</sub>PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study
resolves10.1002/chem.201605801Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy
resolves10.1016/j.jinorgbio.2015.09.012Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies
resolves10.1016/j.talanta.2017.01.074Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments
resolves10.1021/ic402611mPeculiar Features in the Crystal Structure of the Adduct Formed between<i>cis</i>-PtI<sub>2</sub>(NH<sub>3</sub>)<sub>2</sub>and Hen Egg White Lysozyme
resolves10.1039/C7CC06442JProtein metalation by metal-based drugs: X-ray crystallography and mass spectrometry studies
resolves10.1021/cr050004sAg(I) N-Heterocyclic Carbene Complexes: Synthesis, Structure, and Application
resolves10.1021/jo971176vNMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.